CSIMarket
 


Pavmed Inc   (PAVM)
Other Ticker:  
 
 

PAVM's Capital Expenditures Growth by Quarter and Year

Pavmed Inc 's Capital Expenditures results by quarter and year




PAVM Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.30 1.28 0.01
III Quarter September 0.02 0.32 0.04 0.00
II Quarter June 0.02 0.35 0.12 0.04
I Quarter March 0.03 0.57 0.04 0.00
FY   0.07 1.54 1.48 0.05



PAVM Capital Expenditures third quarter 2023 Y/Y Growth Comment
Pavmed Inc reported drop in Capital Expenditures in the third quarter 2023 by -94.38% to $ 0.02 millions, from the same quarter in 2022.
The fall in the third quarter 2023 Pavmed Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 802.47%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 42 other companies have achieved higher Capital Expenditures growth. While Pavmed Inc ' s Capital Expenditures meltdown of -94.38% ranks overall at the positon no. 1092 in the third quarter 2023.




PAVM Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -76.56 % 12700 % -
III Quarter September -94.38 % 700 % - -
II Quarter June -94.29 % 191.67 % 200 % 100 %
I Quarter March -94.74 % 1325 % - -
FY   - 4.05 % 2860 % 150 %

Financial Statements
Pavmed Inc 's third quarter 2023 Capital Expenditures $ 0.02 millions PAVM's Income Statement
Pavmed Inc 's third quarter 2022 Capital Expenditures $ 0.32 millions Quarterly PAVM's Income Statement
New: More PAVM's historic Capital Expenditures Growth >>


PAVM Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -6.25 % 3100 % -
III Quarter September -10 % -8.57 % -66.67 % -
II Quarter June -33.33 % -38.6 % 200 % -
I Quarter March -90 % -55.47 % 300 % -
FY (Year on Year)   - 4.05 % 2860 % 150 %




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #150
Overall #1092

Capital Expenditures Y/Y Growth Statistics
High Average Low
2570.91 % 802.47 % -85.83 %
(Dec 31 2021)   (Sep 30 2023)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #150
Overall #1092
Capital Expenditures Y/Y Growth Statistics
High Average Low
2570.91 % 802.47 % -85.83 %
(Dec 31 2021)   (Sep 30 2023)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Pavmed Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
3548.57 % 278.12 % -100 %
(Dec 31 2021)  


PAVM's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Pavmed Inc realized drop in Capital Expenditures from the second quarter by -10% to $ 0.02 millions, from $ 0.02 millions released in the previous reporting period.

If you evaluate recent shortcoming in the III. Quarter 2023, you must take into consideration, that commonly III. Quarter 2023 results emerge softer in contrast to the quarter before

Within Medical Equipment & Supplies industry 61 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pavmed Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1054.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #62
Healthcare Sector #204
Overall #1054
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #62
Healthcare Sector #204
Overall #1054
Capital Expenditures Q/Q Growth Statistics
High Average Low
3548.57 % 278.12 % -100 %
(Dec 31 2021)  


PAVM's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Pavmed Inc disclosed drop in Capital Expenditures sequentially by -10% to $ 0.02 millions, from $ 0.02 millions released in the previous reporting period.

This is not huge problem, as III. Quarter Capital Expenditures always tend to dip in the III. Quarter Simone Greco, Medical Equipment & Supplies industry advisor from New York told.

Within Medical Equipment & Supplies industry 61 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pavmed Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1054.


Pavmed Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.36 $ 0.66 $ 0.99 $ 1.54 $ 2.52
Y / Y Capital Expenditures Growth (TTM) -85.83 % -70.73 % -50.57 % 4.83 % 1159.5 %
Year on Year Capital Expenditures Growth Overall Ranking # 13 # 10 # 6 # 8 # 43
Seqeuential Capital Expenditures Change (TTM) -45.5 % -33.97 % -35.58 % -38.86 % 12.56 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1092 # 1053 # 671 # 50 # 836




Cumulative Capital Expenditures growth Comment
Pavmed Inc 's cumulative 12 months Capital Expenditures continue to drop, but on the faster rate at -85.83% year on year, at Sep 30 2023 compare to the -70.73% decrease at Jun 30 2023. If the Pavmed Inc 's fiscal year would end at Sep 30 2023, annual Capital Expenditures would be $0 millions.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 10 to 13.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
2570.91 %
802.47 %
-85.83 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 43
Healthcare Sector # 3
Overall # 13

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2570.91 %
802.47 %
-85.83 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 43
Sector # 150
S&P 500 # 1092
Cumulative Capital Expenditures growth Comment
Pavmed Inc 's cumulative 12 months Capital Expenditures continue to drop, but on the faster rate at -85.83% year on year, at Sep 30 2023 compare to the -70.73% decrease at Jun 30 2023. If the Pavmed Inc 's fiscal year would end at Sep 30 2023, annual Capital Expenditures would be $0 millions.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 10 to 13.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
2570.91 %
802.47 %
-85.83 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 43
Healthcare Sector # 3
Overall # 13

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2570.91 %
802.47 %
-85.83 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 43
Sector # 150
S&P 500 # 1092




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PAVM's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PAVM's Competitors
Capital Expenditures Growth for Pavmed Inc 's Suppliers
Capital Expenditures Growth for PAVM's Customers

You may also want to know
PAVM's Annual Growth Rates PAVM's Profitability Ratios PAVM's Asset Turnover Ratio PAVM's Dividend Growth
PAVM's Roe PAVM's Valuation Ratios PAVM's Financial Strength Ratios PAVM's Dividend Payout Ratio
PAVM's Roa PAVM's Inventory Turnover Ratio PAVM's Growth Rates PAVM's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com